Cardiac Computed Tomography for Amyloidosis

Purpose of Review Detecting cardiac amyloid (CA) is challenging. Traditional approaches have not always succeeded in achieving a timely diagnosis. Cardiac magnetic resonance imaging (CMR) has begun to change this, but access to CMR may be limited due to availability or contraindications and may not be considered if clinical suspicion is not high. In contrast, cardiac CT (CCT) is widely available, fast, and has few contraindications. In this review, we will consider the role of CCT to identify CA using anatomy, function, and tissue characteristics. Recent Findings We discuss the different CT protocols that have been employed and reflect on the emerging data. It is likely that CCT will complement existing modalities. It will help detect disease sooner and allow therapy to start earlier. Thus, CT may yet shed light on CA and provide a brighter future for patients.